OAF Antibody Blocking peptide
OAF Antibody Blocking peptide
Product Specifications
Product Name Alternative
Out at first protein homolog, HCV NS5A-transactivated protein 13 target protein 2, OAF, NS5ATP13TP2
UniProt
Q86UD1
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the N-term region of OAF. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Cyanine 5 amine [equivalent to Cy5® amine]](https://cdn.genprice.uk/products/271/7358510/imageurl/155-aat.webp)
BNCB1527-100 1x 100 µL
Bcl-6 (Follicular Lymphoma Marker) (BCL6/1527), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
MCSTDF-SB75/100/W 10x 96 Well Plates
Streptavidin High Binding Coated - 96 well Solid plates - Clear PS
Sign In for Pricing
View Details 
BNC682746-100 1x 100 µL
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details